Epoch

We're building a synthetic biology platform to enable us to make biology fundamental to every industry in earth - we've started by developing an enzyme to break down every kind of plastic.

Based based in Paris, France, Epoch works in sustainability.

Profile

"Epoch is a pioneering company in the New Materials & Packaging and Sustainability industries, dedicated to building a synthetic biology platform that integrates biology into every sector on Earth. Leveraging 20 years of research by Professor Douglas Kell, CBE, Epoch is developing a computational platform for intelligent enzyme design. By utilizing advanced AI, Deep Learning, lab automation, and genomic sequencing, the company can efficiently create enzymes tailored to specific needs. Epoch's groundbreaking achievement lies in the development of a plastic-eating enzyme capable of breaking down various types of plastics, addressing the global plastics crisis. This innovation enables the conversion of plastics into chemicals for polymer manufacturing and industrial processes, enhancing sustainability and cost-competitiveness in biomaterials and specialty chemicals. With a vision for a healthy, equitable, and sustainable world, Epoch is poised to revolutionize multiple industries by harnessing the power of biology."

The company sits in the sustainability segment, where it competes on its core product or service.

Paris, France is where the company is located.

Directory data places it at the Plug and Play accelerated startup stage.

Website: www.epochbiodesign.com